ArticleSouth Asian journal of cancer2025

Safety of Abemaciclib in Indian Patients with Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Locally Advanced and/or Metastatic Breast Cancer: A Multicenter, Nonrandomized, Open-Label, Single-Arm, Phase 4 Study.

Dinesh Chandra Doval et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.